This article has been updated with analysts' EPS estimate and a stock quote.
 
NEW YORK (GenomeWeb News) - Bio-Rad Laboratories today reported a 30 percent increase in third-quarter revenues, driven by its acquisition last year of DiaMed Holdings, but charges related to the acquisition cut into the firm’s profit for the quarter.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.